Braskem Aims to Reach Creditor Deal by Wednesday as Package Shrinks to $4 Billion Relevance8,0
Intermediate PTENES

Braskem Aims to Reach Creditor Deal by Wednesday as Package Shrinks to $4 Billion

Negotiations stalled after Petrobras trimmed its capital injection, lowering the proposed package to $4 billion and heightening dilution risk for BRKM5 holders.

According to two sources familiar with the discussions who spoke to Reuters, Braskem's shareholders and creditors are aiming to reach an out-of-court debt restructuring agreement by this Wednesday (November 11). For holders of BRKM5 preferred shares, the deal addresses the question that has weighed on the stock since August: how much of the company will remain with current shareholders after creditors swap a portion of their debt for equity.

Will Braskem Reach a Deal with Creditors This Wednesday?

That is what the parties want, but the date is non-binding. Shareholders and creditors of the petrochemical company aim to conclude extrajudicial restructuring negotiations by Wednesday, two sources close to the talks told Reuters on Monday, in a report republished by InfoMoney. Wednesday serves as an informal target rather than a legal deadline. The hard deadline is November 22, when the company must present a court-approved plan backed by the parties, covering approximately $10.9 billion in unsecured financial obligations, including senior notes and debentures.

There is a slight discrepancy regarding the timeline. BM&C cites November 23, 2026, as the deadline for Braskem to submit an updated plan accompanied by the adherence of creditors holding more than 50% of the covered claims. Under either version, the absolute limit is 90 days from the initial filing made on August 24. Braskem has not confirmed the Wednesday target; in a statement, the company said it maintains communications with the market in accordance with applicable regulations and that material facts will be disclosed through official channels.

The real news lies in the size of the package, which has shrunk.

What Changed at the Negotiating Table?

An attempt to reach an agreement with bondholders in New York fell through last week due to disagreements over the scale of the transaction. Following that setback, the sources said the group is now working toward a total capitalization agreement of roughly $4 billion—about $1 billion less than previously discussed. The impasse stemmed from Petrobras: bondholders reportedly rejected a $3.8 billion debt-to-equity conversion after Petrobras reduced its planned capital injection from $1.7 billion to $1.4 billion. The state-controlled oil giant cut $300 million, or 17.6% of its pledged amount, and creditors refused to convert more debt into equity while less fresh money was coming in. The table below illustrates how the proposals have shifted:

StageNew CapitalDebt Converted to EquityOutcome
Braskem Proposal (Oct.)$1.2 billion guaranteed in a $2.25 billion offering$2.8 billionRejected
Creditors Counterproposal (Oct.)$1.85 billion requested contribution$1.85 billionNot accepted
New York Round (Nov.)Petrobras: from $1.7 billion to $1.4 billion$3.8 billionRejected
Current Negotiation~ $4 billion total (breakdown not disclosed)Ongoing

The first two rows stem from the material fact filing on October 24. In that company proposal, creditors would convert $2.8 billion into equity, while primary shareholders and third parties committed to injecting $1.2 billion through a subsequent $2.25 billion offering. As we noted when Braskem prepared a new proposal following creditor resistance, the disagreement was never about whether to convert debt. It was always about how much to convert and at what price. The source did not disclose how the current $4 billion is split between fresh capital and debt conversion, and that breakdown will determine the extent of dilution.

Is a smaller package good or bad for shareholders? It depends on what comes with it.

What Does This Mean for BRKM5 Holders?

Minority shareholders have no vote in the process. In an extrajudicial restructuring, the plan is approved by creditors, who require support from more than half of the claims. Initial backing stood at 39.6% of the claims subject to the plan. By our calculations, about 10.4 percentage points are missing—roughly $1.1 billion in claims (10.4% of $10.9 billion) that still need to sign on.

Converting less debt into equity might seem like relief: fewer new shares mean less dilution. On the flip side, the company is left with a heavier debt load. According to estimates from UBS BB, Braskem needs to reduce its net debt by roughly $6 billion to $6.5 billion to reach sustainable levels. Even if every dollar of the current package went toward reducing debt, a gap of $2 billion to $2.5 billion would still remain by our estimate. That remainder would have to be addressed through maturity extensions and the capitalization of interest, which ease cash flow now but do not reduce the principal. The same bank calculated that if the restructuring consists exclusively of debt conversion or a capital increase, minority shareholder dilution would be severe, potentially ranging between roughly 70% and 95%.

Analysts do not expect a favorable outcome for minority investors. Four days ago, Citi cut its price target from R$ 4.50 to R$ 2.75 and downgraded the stock to sell, citing weak spreads and dilution risk. On October 26, XP placed its recommendation and estimates for BRKM5 under review amid ongoing uncertainty regarding shareholder equity. Looking ahead, three paths are possible:

Deal on Wednesday11/11

A material fact disclosure outlines the final terms. Dilution shifts from an estimate to a concrete figure, and volatility is likely to subside.

Delayed, but meets deadlineby 11/22

The target slips once again, as in previous rounds, but the plan reaches the courts with over 50% backing.

Insufficient support<50%

Missing the November 22 deadline pushes the company toward formal bankruptcy protection, a scenario of heightened uncertainty for shareholders.

Why is it unwise to count on the Wednesday deadline? Because no intermediate target has been met so far.

How Many Times Has This Deadline Been Postponed?

At least three times. The schedule has already been pushed back from the initial October target and could be revised once more, sources say. The timeline illustrates how far the informal goals have slipped:

08/24Extrajudicial restructuring filing with 39.6% of claims backing the plan
10/09First target for main terms, postponed
10/30Second target, extended without consensus
11/08Desired date for terms, following the New York breakdown
11/11Current target, according to Reuters sources
11/2290-day court deadline

From the outset, the stock's decline has mirrored every step of this trajectory, from the injunction against creditors in June to the plunge triggered by the extrajudicial recovery filing. The root of the problem remains unchanged: cash flow has been squeezed simultaneously by the land subsidence issue in Maceió and tumbling petrochemical prices.

And the Questions That Follow Right Behind?

Does Petrobras remain in control? Under the company's original proposal, yes: Petrobras and IG4 Capital Group would retain control and management of Braskem. However, the reduction in the state-owned oil company's capital injection weakens that position. The less money the controlling shareholder contributes, the more equity creditors tend to demand. Petrobras and IG4, which formally became co-controllers of Braskem this year, declined to comment.

Will minority shareholders be able to inject capital to avoid dilution? The proposals contemplate a share offering, which typically grants subscription rights to existing shareholders. However, the offering rules have not yet been established. For now, dilution depends on the final terms, and neither a date nor a price has been set for the offering.

Do financial results change anything? They alter the calendar. Third-quarter earnings are set for release on November 12, but the focus remains squarely on the restructuring. If a deal is reached on Wednesday, the quarterly figures will be evaluated with the new capital structure already in mind.

1

Material fact with final terms: the breakdown of the $4 billion between fresh capital and converted debt, alongside the conversion price. This is what turns dilution from an estimated range into a hard number.

2

Creditor support: moving past the initial 39.6% to secure over 50% of claims by November 22. Falling short revives the risk of formal bankruptcy protection.

3

Petrobras capital contribution: whether the investment stays at $1.4 billion or returns closer to $1.7 billion serves as a signal of how vigorously the controlling shareholder defends its stake.

4

Q3 earnings on November 12: cash burn and leverage metrics, weighed against the debt reduction delivered by the agreement.